New study aims to improve pain control for kids after hip surgery

NCT ID NCT07385352

Not yet recruiting Symptom relief Sponsor: Assiut University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two medicines, dexmedetomidine and ketamine, added to a standard painkiller (bupivacaine) given through a caudal block to control pain after hip surgery in children aged 1 to 6 years. The goal is to see which combination provides better pain relief, lasts longer, and reduces the need for extra pain medicine. Fifty-four children will take part, and their pain will be measured using a special scale for the first 24 hours after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dexmedetomidine and Ketamine (added to Bupivacaine)
What this could lead to: If it works, this could point toward a safer, longer-lasting pain relief option for children after hip surgery.
What could go wrong: This is a small, early-stage study with only 54 children. It may not show a clear benefit, and results may not apply to all children or surgeries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEVELOPMENTAL DYSPLASIA OF THE HIP are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

developmental dysplasia of the hip

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEVELOPMENTAL DYSPLASIA OF THE HIP

Contacts and locations

Locations

Assiut University Hospital

Asyut, Asyut Governorate, 71515, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.